Kit for preparation of 99mTc-MIBI
| Primena | -myocardial perfusion scintigraphy for the detection and localisation of coronary artery disease (angina pectoris and myocardial infarction) -assessment of global ventricular function. First- pass technique for determination of ejection fraction and/or ECG-triggered, gated SPECT for evaluation of left ventricular ejection fraction, volumes and regional wall motion. -scintimammography for the detection of suspected breast cancer when mammography is equivocal, inadequate or indeterminate. -localisation of hyperfunctioning parathyroid tissue in patients with recurrent or persistent disease in both primary and secondary hyperparathyroidism, and in patients with primary hyperparathyroidism scheduled to undergo initial surgery of the parathyroid glands. |
| Farmaceutski oblik | radiopharmaceutical kit |
| Veličina pakovanja | 5 vials in the cardboard box |
| Sadržaj po bočici | 1 mg of copper tetraMIBI tetrafluoroborate [Cu(MIBI)4]BF4 0.075 mg of SnCl2x2H2O 1 mg of L-cysteine hydrochloride monohydrate 2.6 mg Na-citrate dihydrate 20 mg of mannitol |
| Izgled | lyophilized, white powder |
| Karakteristike rastvora nakon obeležavanja | volume of 1 - 5 ml radiochemical purity: > 94 % pH of the solution: 5.0 - 6.0 clear, colorless solution |
| Stabilnost rastvora nakon obeležavanja | 10 hours at a temperature below 25 ºC |
| Rok upotrebe | one year from the production date |
| Čuvanje | in a refrigerator (2-8 ºC) |
| Isporuka | from stock |
